The DOI matches its Crossref record; 22 of the 22 references it cites were found in a registry or an index.
Burden and centralised treatment in Europe of rare tumours: results of RARECAREnet—a population-based study
Open accessAbstract
Background Rare cancers pose challenges for diagnosis, treatments, and clinical decision making. Information about rare cancers is scant. The RARECARE project defined rare cancers as those with an annual incidence of less than six per 100 000 people in European Union (EU). We updated the estimates of the burden of rare cancers in Europe, their time trends in incidence and survival, and provide information about centralisation of treatments in seven European countries.Methods We analysed data from 94 cancer registries for more than 2 million rare cancer diagnoses, to estimate European incidence and survival in 2000-07 and the corresponding time trends during 1995-2007. Incidence was calculated as the number of new cases divided by the corresponding total person-years in the population. 5-year relative survival was calculated by the Ederer-2 method. Seven registries (Belgium, Bulgaria, Finland, Ireland, the Netherlands, Slovenia, and the Navarra region in Spain) provided additional data for hospitals treating about 220 000 cases diagnosed in 2000-07. We also calculated hospital volume admission as the number of treatments provided by each hospital rare cancer group sharing the same referral pattern.Findings Rare cancers accounted for 24% of all cancers diagnosed in the EU during 2000-07. The overall incidence rose annually by 0.5% (99·8% CI 0·3-0·8). 5-year relative survival for all rare cancers was 48·5% (95% CI 48·4 to 48·6), compared with 63·4% (95% CI 63·3 to 63·4) for all common cancers. 5-year relative survival increased (overall 2·9%, 95% CI 2·7 to 3·2), from 1999-2001 to 2007-09, and for most rare cancers, with the largest increases for haematological tumours and sarcomas. The amount of centralisation of rare cancer treatment varied widely between cancers and between countries. The Netherlands and Slovenia had the highest treatment volumes.Interpretation Our study benefits from the largest pool of population-based registries to estimate incidence and survival of about 200 rare cancers. Incidence trends can be explained by changes in known risk factors, improved diagnosis, and registration problems. Survival could be improved by early diagnosis, new treatments, and improved case management. The centralisation of treatment could be improved in the seven European countries we studied.Funding The European Commission (Chafea).
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“However, translating the capabilities of current patch-based foundation models to address patient- and slide-level clinical challenges still remains complex due to the immense scale of gigapixel WSIs, compounded by the small size of patient cohorts in real-world evidence39–42, especially for rare diseases with limited training data43–45.”
From A multimodal whole-slide foundation model for pathology (2025) · cites this paper as [43]
Experimental — accuracy not yet measured
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
International Classification of Diseases for Oncology
National Cancer Institute (2020) · Definitions · doi:10.32388/1bjeus · Cited by 3,810
Angelis, R. D., Sant, M., Coleman, M. P., Francisci, S., Baili, P., Pierannunzio, D., Trama, A., Visser, O. J., Brenner, H., Ardanáz, E., et al. (2013) · The Lancet Oncology · doi:10.1016/s1470-2045(13)70546-1 · Cited by 1,888
Self-citationWorldwide Thyroid-Cancer Epidemic? The Increasing Impact of Overdiagnosis
Vaccarella, S., Franceschi, S., Bray, F., Wild, C. P., Plummer, M., & Dal Maso, L. (2016) · New England Journal of Medicine · doi:10.1056/nejmp1604412 · Cited by 1,145
Rare cancers are not so rare: The rare cancer burden in Europe
Gatta, G., van der Zwan, J. M., Casali, P. G., Siesling, S., Tos, A. P. D., Kunkler, I. H., Otter, R., Licitra, L. F., Mallone, S., Tavilla, A., et al. (2011) · European Journal of Cancer · doi:10.1016/j.ejca.2011.08.008 · Cited by 813
Self-citationHuman papillomavirus related head and neck cancer survival: A systematic review and meta-analysis
O’Rorke, M. A., Ellison, M. V., Murray, L., Moran, M., James, J. A., & Anderson, L. A. (2012) · Oral Oncology · doi:10.1016/j.oraloncology.2012.06.019 · Cited by 422
Self-citationHeck, J. E., Berthiller, J., Vaccarella, S., Winn, D. M., Smith, E., Shangina, O., Schwartz, S. M., Purdue, M. P., Pilarska, A., Eluf‐Neto, J., et al. (2009) · International Journal of Epidemiology · doi:10.1093/ije/dyp350 · Cited by 385
Recent changes in the epidemiology of head and neck cancer
Curado, M. P., & Hashibe, M. (2009) · Current Opinion in Oncology · doi:10.1097/cco.0b013e32832a68ca · Cited by 354
Kantarjian, H. M., O'Brien, S. M., Jabbour, E. J., Garcia‐Manero, G., Quintás‐Cardama, A., Shan, J., Rios, M. B., Ravandi, F., Faderl, S. H., Kadia, T. M., et al. (2012) · Blood · doi:10.1182/blood-2011-08-358135 · Cited by 335
Sant, M., Minicozzi, P., Mounier, M., Anderson, L. A., Brenner, H., Holleczek, B., Marcos‐Gragera, R., Maynadié, M., Monnereau, A., Osca‐Gelis, G., et al. (2014) · The Lancet Oncology · doi:10.1016/s1470-2045(14)70282-7 · Cited by 292
Self-citationLepage, C., Capocaccia, R., Hackl, M., Lemmens, V., Molina‐Montes, E., Pierannunzio, D., Sant, M., Trama, A., Faivre, J., Hackl, M., et al. (2015) · European Journal of Cancer · doi:10.1016/j.ejca.2015.07.034 · Cited by 149
Self-citation
Research works printed but not linked: 1
- Ederer, 1961, The relative survival: a statistical methodology, Natl Cancer Inst Monogr, 6, 101
Cited by
Sorted by citations
Items 301–400 of 517
Keskin, A., Yorulmaz, E. M., Dönmez, K., Özcan, S., Köse, O., Görgel, S. N., & Akın, Y. (2025) · Frontiers in Urology · doi:10.3389/fruro.2025.1619185 · Cited by 3
Performance of Finnish biobanks in nationwide pulmonary carcinoid tumour research
Vesterinen, T., Salmenkivi, K., Mustonen, H. K., Kuopio, T., Lappi‐Blanco, E., Paavonen, T., Vainio, P., Knuuttila, A., Carpén, O., Haglund, C. H., et al. (2019) · Archiv für Pathologische Anatomie und Physiologie und für Klinische Medicin · doi:10.1007/s00428-019-02625-6 · Cited by 3
Poorly-differentiated and undifferentiated sarcomas of the mediastinum: a bag of tricks
Renne, S. L., & Tommaso, L. D. (2021) · Mediastinum · doi:10.21037/med-20-54 · Cited by 3
Cobián, C. D., Blaakær, J., Eriksson, A. G. Z., Herrstedt, J., Vandborg, M., Rasmussen, A. M. O., & Fuglsang, K. (2022) · Acta Oncologica · doi:10.1080/0284186x.2022.2088249 · Cited by 3
The role of HPV status in patients with overlapping grey zone cancer in oral cavity and oropharynx
Song, Y., Cheng, D., Yi, X., Rao, Y., Qiu, K., Mao, M., Pang, W., Li, J., Zheng, Y., Feng, R., et al. (2022) · European Archives of Oto-Rhino-Laryngology · doi:10.1007/s00405-022-07713-z · Cited by 3
Increased Incidence of Rare Cancer and Varied Age Distributions by Cancer Group in Hiroshima, Japan
Sugiyama, H., Konda, M., Saika, K., Trama, A., & Matsuda, T. (2022) · Cancer Epidemiology · doi:10.1016/j.canep.2023.102336 · Cited by 3
Self-citationHamid, M., Joyce, C. M., Carroll, H. K., Kenneally, C., Mulcahy, S., O'Neill, M.-K., Coulter, J., & O’Reilly, S. (2023) · European Journal of Obstetrics & Gynecology and Reproductive Biology · doi:10.1016/j.ejogrb.2023.05.016 · Cited by 3
Novel trial designs for patients with gastrointestinal stromal tumor
Serrano, C., Rothschild, S., Villacampa, G. J., Heinrich, M. C., George, S., Blay, J., Sicklick, J. K., Schwartz, G. K., Rastogi, S., Jones, R. L., et al. (2024) · ESMO Open · doi:10.1016/j.esmoop.2023.102218 · Cited by 3
Epigenetic determinants in soft tissue sarcomas: molecular mechanisms and therapeutic targets
Merlini, A., Rabino, M., Brusco, S., Pavese, V., Masci, D., Sangiolo, D., Bironzo, P., Scagliotti, G. V., Novello, S., & D’Ambrosio, L. (2024) · Expert Opinion on Therapeutic Targets · doi:10.1080/14728222.2024.2306344 · Cited by 3
Matsuoka, M., Onodera, T., Iwasaki, K., Hamasaki, M., Ebata, T., Hosokawa, Y., Fukuda, R., Kondo, E., & Iwasaki, N. (2024) · Foot and Ankle Surgery · doi:10.1016/j.fas.2024.05.016 · Cited by 3
Cicala, C. M., Matito, J., Quindós, M., Gómez-Peregrina, D., Romero-Lozano, P., Fernández-Suárez, P., Valverde, C. M., González, M., Landolfi, S., Pérez‐Albert, P., et al. (2025) · JCO Precision Oncology · doi:10.1200/po-24-00497 · Cited by 3
Fernandez‐Cuesta, L., Voegele, C., Hémon, B., Alcala, K., Aune, D., Caini, S., Casalone, E., Cross, A. J., Ferrari, P., Girard, N., et al. (2025) · ESMO rare cancers. · doi:10.1016/j.esmorc.2025.100014 · Cited by 3
Self-citationRodriguez-Martin, A.-M., Zacharopoulou, P., Hassan, A. B., & Tsiachristas, A. (2018) · Journal of Cancer Policy · doi:10.1016/j.jcpo.2018.08.001 · Cited by 3
Dai, N., Liu, H., Deng, S., Sang, S., & Wu, Y. (2021) · Technology in Cancer Research & Treatment · doi:10.1177/15330338211056478 · Cited by 3
Therapeutic impact and routine application of next‑generation sequencing: A single institute study
Acosta, R., Fuentes, M. D., Pena, N., Rojas, P. S., & Zambrano, C. B. (2022) · Biomedical Reports · doi:10.3892/br.2022.1516 · Cited by 3
Krendyukov, A., Singhvi, S., Green-Morrison, Y., & Zabransky, M. (2022) · Frontiers in Oncology · doi:10.3389/fonc.2022.714516 · Cited by 3
Leiomyosarcoma of the Inferior Vena Cava extending to the Right Atrium and Ventricle
ALGhasab, N. S., Alruwayeh, M., Algharras, A., & Mulji, A. S. (2023) · Journal of the Saudi Heart Association · doi:10.37616/2212-5043.1344 · Cited by 3
Exploring geographical variation in access to general surgery in Ireland
Ahmed, O., Mealy, K., Kelliher, G., Keane, F. B. V., & Sørensen, J. R. (2019) · The Surgeon · doi:10.1016/j.surge.2018.12.005 · Cited by 3
Hooiveld-Noeken, J. S., Fehrmann, R. S. N., de Vries, E. G. E., & Jalving, M. (2019) · Immuno-Oncology Technology · doi:10.1016/j.iotech.2019.11.002 · Cited by 3
Epidemiological Aspects in Nasopharyngeal Cancer
Gatta, G. (2021) · Springer eBooks · doi:10.1007/978-3-030-63234-2_21 · Cited by 3
Self-citationEditor’s foreword: evolving the rare cancer field
O’Connor, D. J. (2018) · Expert Opinion on Orphan Drugs · doi:10.1080/21678707.2018.1520092 · Cited by 3
Lopez-Perez, L. (2022) · doi:10.20868/upm.thesis.70347 · Cited by 3
Ozaniak, A., Galová, D., Benešová, I., Lischke, R., & Strizova, Z. O. (2024) · Journal of Thoracic Disease · doi:10.21037/jtd-24-472 · Cited by 2
Silva, D. D. E., David, B. B. L., de Camargo, V. P., Filipi, R. Z., Donna, M. L. G., Varas, J. C. H., Munhoz, R. R., Zapata, M., Martins, C. L. C. D. S., Chacon, M. R., et al. (2025) · JCO Global Oncology · doi:10.1200/go.24.00239 · Cited by 2
Gijsels, S., Vekeman, M., Fischer, S., Creytens, D., Ackerman, A., Ongenaet, A., Boi, L., Segers, E., Temmerman, J. D., Casteur, F., et al. (2025) · Surgical Oncology · doi:10.1016/j.suronc.2025.102209 · Cited by 2
Vasileva‐Slaveva, M., Yordanov, A. D., Ivanov, I., Nanev, V., Chortova, M., Vlahova, A. I., Simeonova, L., Taushanova, M., Calleja‐Agius, J., Harasani, K., et al. (2025) · European Journal of Surgical Oncology · doi:10.1016/j.ejso.2025.109712 · Cited by 2
The Role of [18F]FDG PET/CT Prior to and During Neoadjuvant Chemotherapy for Soft Tissue Sarcomas
van der Burg, S. J. C., van der Hiel, B., Heimans, L., Kerst, J. M., Wouters, M. W. J. M., Snæbjörnsson, P., Schrage, Y. M., van der Graaf, W. T. A., & van Houdt, W. J. (2025) · Current Oncology · doi:10.3390/curroncol32050257 · Cited by 2
Fukuda, R., Matsuoka, M., Onodera, T., Iwasaki, K., Sato, D., Ebata, T., Shimizu, H., Kondo, E., & Iwasaki, N. (2026) · Cancer Epidemiology · doi:10.1016/j.canep.2026.103055 · Cited by 2
Yu, Q. (2026) · Frontiers in Oncology · doi:10.3389/fonc.2026.1803729 · Cited by 2
Rodríguez, R. G., Rodríguez, E. M. R., Jimena, I., & Leiva‐Cepas, F. (2026) · Healthcare · doi:10.3390/healthcare14121700 · Cited by 2
van der Loo, I., Vroomen, L. G. P. H., Gennaro, N., Hamming‐Vrieze, O., Beets‐Tan, R. G. H., Haas, R. L., Imholz, A. L. T., & Trebeschi, S. (2026) · ESMO rare cancers. · doi:10.1016/j.esmorc.2026.100517 · Cited by 2
Trama, A., Proto, C., Signorelli, D., Garassino, M. C., Russo, G. L., Ganzinelli, M., Prelaj, A., Mensi, C., Gangemi, M., Gennaro, V., et al. (2020) · Thoracic Cancer · doi:10.1111/1759-7714.13456 · Cited by 2
Self-citationIncidence and Prognosis of Biliary Tract and Gallbladder Cancers in a Belgian Academic Hospital
Gilliaux, Q., Faugeras, L., Martinet, J.-P., Ronde, T. D., Badaoui, A., Bertrand, C., Dili, A., Delos, M., Jamart, J., Baily, A., et al. (2020) · Journal of Gastrointestinal Cancer · doi:10.1007/s12029-020-00526-5 · Cited by 2
Emerick, C., Mariano, F. V., SQUARIZE, C. H., & CASTILHO, R. M. (2022) · Oral Diseases · doi:10.1111/odi.14284 · Cited by 2
Patient access – Zugang zu Innovationen in der Onkologie
Berger, K., Westphalen, C. B., & von Bergwelt‐Baildon, M. (2023) · DMW - Deutsche Medizinische Wochenschrift · doi:10.1055/a-1929-6599 · Cited by 2
Onesti, C. E., Vari, S., Minghelli, D., Nardozza, F., Rossi, B., Sperati, F., Checcucci, E., Faltyn, W., Cercato, M. C., Cosimati, A., et al. (2023) · Frontiers in Psychology · doi:10.3389/fpsyg.2023.1078992 · Cited by 2
Tong, Y., Jiang, L., Cui, Y., Pi, Y., Gong, Y., & Zhao, D. (2023) · Frontiers in Oncology · doi:10.3389/fonc.2023.960502 · Cited by 2
Bernatz, S., Böth, I., Ackermann, J., Burck, I., Mahmoudi, S., Lenga, L., Martin, S. S., Scholtz, J., Koch, V., Grünewald, L. D., et al. (2023) · Journal of Computer Assisted Tomography · doi:10.1097/rct.0000000000001551 · Cited by 2
Zhao, G., Wang, Y., Wang, S., & Li, N. (2024) · Clinical Cancer Bulletin · doi:10.1007/s44272-024-00016-w · Cited by 2
How effective is our current follow‐up for patients with hypopharyngeal carcinoma?
Stagl, K., Grasl, S., Erovic, B. M., & Janik, S. (2024) · Head & Neck · doi:10.1002/hed.27881 · Cited by 2
Wu, H., Liu, L., Zhuang, J., Zhong, G., Wei, S., Zeng, L., Zi, Y., Xu, F., Yao, M., & Zhang, Y. (2024) · British Journal of Radiology · doi:10.1093/bjr/tqae188 · Cited by 2
Meeting the Unmet Needs in Rare Cancer
Li, N., Wang, S., & Zhao, G. (2024) · JAMA · doi:10.1001/jama.2024.21396 · Cited by 2
Survival outcomes in non-operative cases of localized extremity sarcoma
Matsuoka, M., Onodera, T., Iwasaki, K., Hamasaki, M., Ebata, T., Hosokawa, Y., Kondo, E., & Iwasaki, N. (2024) · Surgical Oncology · doi:10.1016/j.suronc.2024.102181 · Cited by 2
Spiridon, I. A., Ong, S. L. M., Soukup, J., Topirceanu-Andreoiu, O.-M., de Geus‐Oei, L., Gelderblom, H. A. J., Lam, S. W., Bruijn, I. H. B., van den Akker, B. E. W. M., Hijmen, L., et al. (2025) · Archiv für Pathologische Anatomie und Physiologie und für Klinische Medicin · doi:10.1007/s00428-025-04086-6 · Cited by 2
Exploring the Role of Bioprosthesis for Chest Wall Reconstruction in Pediatric Oncology
Oreglio, C., Grimaldi, C., Gonfiotti, A., Fusi, G., Severi, E., Piccolo, R. L., Beltrami, G., Tamburini, A., Buccoliero, A. M., Cianci, M. C., et al. (2025) · Pediatric Blood & Cancer · doi:10.1002/pbc.32058 · Cited by 2
Descriptive Epidemiology of Hospitalization of Patients with a Rare Tumor in an Italian Region
Rosa, A., Fontana, V., Filiberti, R. A., Pronzato, P., & Mannucci, M. (2022) · Current Oncology · doi:10.3390/curroncol29120762 · Cited by 2
Self-citationHofmann, E., Preißner, S., Hertel, M., Preißner, R., Rendenbach, C., Flörcken, A., & Heiland, M. (2023) · Therapeutic Advances in Medical Oncology · doi:10.1177/17588359221148023 · Cited by 2
Novel biomarkers in bone sarcomas — diagnosis, treatment selection, and clinical trials
Czarnecka, A. M., Błoński, P. J., Chmiel, P., & Rutkowski, P. L. (2024) · Oncology in Clinical Practice · doi:10.5603/ocp.99779 · Cited by 2
tsRNA in head and neck tumors: Opportunities and challenges in the field
wu, Z., Xu, Y., Zhou, C., Zhang, Y., & Chen, J. (2024) · Non-coding RNA Research · doi:10.1016/j.ncrna.2024.10.003 · Cited by 2
Noeuveglise, M., Tessier, W., Barthoulot, M., Decanter, G., Cayeux, A., Marin, H., Lemoine, P., Aymes, E., Taieb, S., Fayard, C., et al. (2024) · BMC Cancer · doi:10.1186/s12885-024-13243-0 · Cited by 2
Chiappetta, M., Lococo, F., Sassorossi, C., Moser, B., Schil, P. E. V., Podobed, A. V., Liberman, M., Opitz, I., Zisis, C., Menghesha, H., et al. (2025) · Lung Cancer · doi:10.1016/j.lungcan.2025.108535 · Cited by 2
Health‐Related Quality of Life in Patients With a Head and Neck Sarcoma: A Mixed‐Methods Study
Koffi, E. K., Padilla, C. S., Drabbe, C., Schreuder, W. H., Zemouri, C., den Hollander, D., Grünhagen, D. J., Sodergren, S. C., Singer, S., Jones, R. L., et al. (2025) · Head & Neck · doi:10.1002/hed.28226 · Cited by 2
Wu, Z., Su, Z., Huang, J., Gluchman, M., & Zhao, C. (2025) · Medicine Advances · doi:10.1002/med4.70032 · Cited by 3
The challenge of rare cancers in nursing care
Charalambous, A., & Biagioli, V. (2022) · European Journal of Oncology Nursing · doi:10.1016/j.ejon.2022.102195 · Cited by 2
Joaquim, A. V., Nobre, A. R., Araújo, C., Vieira, G., Alves, P., Carinha, P., & Ribeiro, L. (2023) · Acta Médica Portuguesa · doi:10.20344/amp.18180 · Cited by 2
Rosati, G., Camerlo, S., Dalmazzo, M., Padrini, M., Busana, T. T., Gobbi, M., Fornari, A., & Morotti, A. (2023) · Hematology Reports · doi:10.3390/hematolrep15030045 · Cited by 2
Case Report: Adult Retroperitoneal Rhabdomyosarcoma
Benjelloun, E. G., Hatim, G., Meryem, Z., Razzouki, I., Bennani, N., Jouhadi, H., Chekrine, T., Bouchbika, Z., Benchekroun, N., Tawfiq, N., et al. (2022) · European Journal of Medical and Health Sciences · doi:10.24018/ejmed.2022.4.6.1519 · Cited by 2
Long term outcome of complex surgical resection and reconstruction for rare thoracic cancers
Pastorino, U., Leuzzi, G., Sabia, F., Girotti, P. N. C., Duranti, L., Redaelli, S., Fiore, M., Stacchiotti, S., Giannatempo, P., Salvioni, R., et al. (2023) · Tumori Journal · doi:10.1177/03008916231154763 · Cited by 2
Sobiborowicz, A., Spalek, M. J., Czarnecka, A. M., & Rutkowski, P. L. (2020) · doi:10.21203/rs.3.rs-30463/v1 · Cited by 2
The European Reference Network: the keystone for the management of rare thoracic cancers
Morra, R. P., D’Ambrosio, A., Pietroluongo, E., Placido, P. D., Montella, L., Deo, V. D., Tortora, M., Placido, S. D., Palmieri, G., & Giuliano, M. (2022) · Mediastinum · doi:10.21037/med-22-10 · Cited by 2
Roitman, P. D. (2024) · Springer eBooks · doi:10.1007/978-3-031-30518-4_180 · Cited by 2
External validation of prognostic and predictive gene signatures in head and neck cancer patientsPreprint
Fossen, E. I. F., Moreira-Soares, M., LeBlanc, M., Frigessi, A., Hovig, E. J., Lopez-Perez, L., Estévez-Priego, E., Hernández, L., Cabrera-Umpiérrez, M. F., Fico, G., et al. (2024) · medRxiv · doi:10.1101/2024.09.24.24314278 · Cited by 2
Kabra, M., Margotto, L., & Manuguid, F. (2021) · Future Oncology · doi:10.2217/fon-2021-0179 · Cited by 1
Activation of Wnt Pathway Suppresses Growth of MUG-Chor1 Chordoma Cell Line
Şişli, H. B., Hayal, T. B., Şenkal, S., Okumuş, E. B., Kıratlı, B., Asutay, A. B., Şahi̇n, F., Bayrak, Ö. F., & Doğan, A. (2023) · Cell Biochemistry and Biophysics · doi:10.1007/s12013-023-01178-5 · Cited by 1
A single centre experience of patients with rare cancers referred for early phase clinical trials
Angelakas, A., Cook, N., Graham, D. M., Krebs, M., Thistlethwaite, F. C., & Carter, L. (2025) · BMC Cancer · doi:10.1186/s12885-025-13934-2 · Cited by 1
Bergsma, P., Porazinski, S. R., Istadi, A., Fajardo, D. C., Mahmood, Y., Lombardi, S., Schuhmacher, D., Barraclough-Franks, H., Strbenac, D., Dennis, C. V., et al. (2025) · Molecular Cancer Therapeutics · doi:10.1158/1535-7163.mct-24-0704 · Cited by 1
Xu, C., Li, F., Li, Z., He, C., Feng, Y., Cui, L., Zhang, L., & Li, X. (2025) · Pathology - Research and Practice · doi:10.1016/j.prp.2025.156147 · Cited by 1
Strohäker, J., Strauß, D., Smith, M. J. F., Thway, K., Miah, A. B., Zaidi, S., Benson, C., Jones, R. L., & Hayes, A. J. (2025) · European Journal of Surgical Oncology · doi:10.1016/j.ejso.2025.110448 · Cited by 1
Fasano, M., Perri, F., Pirozzi, M., Deantoni, C. L., Valsecchi, D., Cirillo, A., Addeo, R., Vitale, P., Felice, F. D., Tralongo, P., et al. (2025) · Cancers · doi:10.3390/cancers17213550 · Cited by 1
Zhang, L., Yang, B. T., Qu, X., Huang, C., Meng, Z., Liu, H., Chen, X., & Xian, J. (2025) · British Journal of Radiology · doi:10.1093/bjr/tqaf276 · Cited by 1
SEOM–TTCC clinical guidelines for the treatment of head and neck cancer (2025)
Arrazubi, V., Iglesias, L., Oliva, M., Segura, P. P., Rubió‐Casadevall, J., Bruixola, G., Carral, A., Castelo, B., Cirauqui, B., & Rueda, A. (2026) · Clinical & Translational Oncology · doi:10.1007/s12094-026-04240-9 · Cited by 1
Lasalvia, M., Caponio, V. C. A., Gristina, R., Cosmai, S., Capozzi, V., Biamonte, F., Battaglia, A. M., Sardella, E., Perrotti, V., & Perna, G. (2026) · Vibrational Spectroscopy · doi:10.1016/j.vibspec.2026.103913 · Cited by 1
Rikitake, R., Mizushima, Y., Yamamoto, Y., Higashi, T., Sakai, T., Kawai, A., & Asakage, T. (2026) · International Journal of Clinical Oncology · doi:10.1007/s10147-025-02952-6 · Cited by 1
López, J. A. G., Sebio, A., Martín‐Broto, J., Hindi, N., Villarejo‐Campos, P., Fuertes, M. J., Beveridge, R. D., Castellanos, J. F. O., Andujar, R. L., Álvarez-Álvarez, R., et al. (2026) · Annals of Surgical Oncology · doi:10.1245/s10434-026-19487-3 · Cited by 1
Self-citationGennari, P., & Ignatov, A. (2026) · Cancers · doi:10.3390/cancers18091415 · Cited by 1
Cuenin, M., Lévy, A., Peiffert, D., Sunyach, M.-P., Ducassou, A., Córdoba, A., Gillon, P., Thibouw, D., Lapeyre, M., Lerouge, D., et al. (2024) · Clinical and Translational Radiation Oncology · doi:10.1016/j.ctro.2024.100825 · Cited by 1
Giordano, V., Guillari, A., Lanzuise, A., Virgolesi, M., Vaio, L. D., & Rea, T. (2024) · NSC Nursing · doi:10.32549/opi-nsc-111 · Cited by 1
Schiappacassi, M., Spizzo, R., Polesel, J., Musco, L., Doliana, R., Pellizzari, L., Lupato, V., Fanetti, G., Vaccher, E., Serraino, D., et al. (2024) · Translational Oncology · doi:10.1016/j.tranon.2024.102221 · Cited by 1
Self-citationAnczykowski, M. Z., Rösel, P., Ziegler, D. A., Fischer, L. A., Guhlich, M., Shafie, R. A. E., Rieken, S., Dröge, L. H., & Leu, M. (2025) · Frontiers in Oncology · doi:10.3389/fonc.2025.1567655 · Cited by 1
Le Normand, N., Cornet, É., J-M, P., Lancesseur, C., Maître, E., Bardet, H., Damaj, G. L., & Troussard, X. (2025) · Clinical Lymphoma Myeloma & Leukemia · doi:10.1016/j.clml.2025.07.010 · Cited by 1
Self-citationSköld, C., Rådestad, A. F., Bohlin, K. S., Bjurberg, M., Borgfeldt, C., Hellman, K., Jönsson, J.-M., Kjølhede, P., Lundqvist, E. Å., Olsson, C., et al. (2025) · Gynecologic Oncology · doi:10.1016/j.ygyno.2025.10.019 · Cited by 1
Miliziano, D., Sciortino, C., Manglaviti, S., Ganzinelli, M., Lopez-Gutierrez, A., Occhipinti, M. A., Proto, C., de Braud, F., Besse, B., Russo, G. L., et al. (2025) · Cancer Treatment Reviews · doi:10.1016/j.ctrv.2025.103049 · Cited by 1
Gao, X., Liu, Z., Xu, Z., Liu, K., Zhang, Y., Yu, J., Wang, X., Chen, H., Ni, C., Wang, P., et al. (2026) · Cellular Oncology · doi:10.1007/s13402-026-01172-y · Cited by 1
Simonet, T. M., Bertelli, C., Mraihi, H., Opota, O., Poirel, L., Tissot, F., & Lemaire, B. (2026) · BMC Infectious Diseases · doi:10.1186/s12879-026-13292-9 · Cited by 1
Oncogenic driver and therapeutic target: Prolactin signalling axis in retroperitoneal sarcoma
Xie, F., Gu, L., Yang, K., Wang, S., Xiao, M., Yan, G., Zhang, Q., Liang, R., Zhuang, A., Xi, Z., et al. (2026) · Clinical and Translational Medicine · doi:10.1002/ctm2.70669 · Cited by 1
SENTINEL LYMPH NODE BIOPSY AS A PROGNOSTIC TOOL IN EARLY ORAL CANCER USING METHYLENE BLUE DYE
Elshamaa, M. M., Fata, M., Swaify, G. A., Hegab, S. E.-S., & Tayel, H. (2020) · Alexandria Dental Journal · doi:10.21608/adjalexu.2020.88453 · Cited by 1
Multimodale Therapie der lokalisierten High-grade-Weichgewebesarkome der Extremitäten
Schopow, N., Hohenberger, P., Gockel, I., & Osterhoff, G. (2023) · Die Chirurgie · doi:10.1007/s00104-023-01872-3 · Cited by 1
Case Report: Response to ipilimumab and nivolumab in a patient with adrenocortical carcinoma
Charles, R., Madhu, D., Powles, A., Boyde, A., Hughes, O., Kumar, N., & Moorcraft, S. Y. (2023) · Frontiers in Oncology · doi:10.3389/fonc.2023.1242560 · Cited by 1
A glimpse into the future: mapping global research trends in immunotherapy for rare tumors
Zhao, G., Wang, Y., Wang, S., & Li, N. (2023) · Journal of the National Cancer Center · doi:10.1016/j.jncc.2023.11.002 · Cited by 1
Demirdöver, C., Geyik, A., Vayvada, H., Menderes, A., & Geyik, S. G. (2023) · Journal of Dermatology & Dermatologic Surgery · doi:10.4103/jdds.jdds_1_23 · Cited by 1
Introducing the PLOS collection on rare cancer
Borad, M. J. (2024) · PLoS ONE · doi:10.1371/journal.pone.0308087 · Cited by 1
Individualized vaginal applicator for stage IIb primary vaginal adenocarcinoma: A case report
Saijilafu, Gu, Y.-J., Huang, A.-W., Xu, C.-F., & Qian, L.-W. (2024) · World Journal of Clinical Oncology · doi:10.5306/wjco.v15.i8.1102 · Cited by 1
Døssing, R. H., Broman, J. J. A., O’Rourke, C. J., Tabaksblat, E. M., Andersen, J. B., Hansen, C. P., Poulsen, T. S., Høgdall, E. V. S., Schou, J. V., & Høgdall, D. (2025) · BMC Cancer · doi:10.1186/s12885-024-13369-1 · Cited by 1
Pain Accelerates, Swelling and Sensory Disturbances Delay Diagnosis in Mesenchymal Tumors
Elyes, M., Heesen, P., Schelling, G., Bode‐Lesniewska, B., Studer, G., Fuchs, B., & on behalf of the Swiss Sarcoma Network (2025) · Cancers · doi:10.3390/cancers17030510 · Cited by 1
Validity and Reliability of the Self‐Care in MyeloProliferative Neoplasms Inventory (SC‐MPNI)
Biagioli, V., Inzoli, A., Barone, A., Iurlo, A., Guglielmelli, P., Palandri, F., Mora, B., Impera, S. S., Betti, S., Santoro, M., et al. (2025) · European Journal of Cancer Care · doi:10.1155/ecc/8353115 · Cited by 1
Редките тумори – епидемиологични и общественоздравни аспекти
Iskrov, G. G., & Stefanov, R. S. (2018) · Редки болести и лекарства сираци · doi:10.36865/2018.v9i4.59 · Cited by 1
NEUROENDOCRINE NEOPLASMS IN ITALY
Mangone, L., Bisceglia, I., Sacchettini, C., Mancuso, P., Carlinfante, G., Rossi, P. G., & A. AIRTUM Working Group (2021) · Annals of Research in Oncology · doi:10.48286/aro.2021.14 · Cited by 1
Self-citationAl-Danakh, A. Y., Safi, M., Alradhi, M., Zhu, X., & Yang, D. (2022) · Surgical Oncology · doi:10.1016/j.suronc.2022.101807 · Cited by 1
Digit ratio (2D:4D), laryngeal cancer and vocal fold leukoplakia
Pietruszewska, W., Morawska, J., Manning, J. T., Sitek, A., Antoszewski, B., & Kasielska‐Trojan, A. (2023) · Journal of Cancer Research and Clinical Oncology · doi:10.1007/s00432-023-04850-8 · Cited by 1
Role of radiotherapy in the management of rare solid thoracic tumors of the adults
Buchalet, C., & Durdux, C. (2023) · Cancer/Radiothérapie · doi:10.1016/j.canrad.2023.06.025 · Cited by 1
Metadata
- Authors
- Gatta, G., Capocaccia, R., Botta, L., Mallone, S., De Angelis, R., Ardanaz, E., Comber, H., Dimitrova, N., Leinonen, M. K., Siesling, S., van der Zwan, J. M., Van Eycken, L., Visser, O., Žakelj, M. P., Anderson, L. A., Bella, F., Kaire, I., Otter, R., Stiller, C. A., Trama, A., Hackl, M., Henau, K., Van Damme, N., Valerianova, Z., Sekerija, M., Dušek, L., Mägi, M., Paapsi, K., Malila, N., Velten, M., Troussard, X., Bouvier, V., Guizard, A.-V., Bouvier, A.-M., Arveux, P., Maynadié, M., Woronoff, A.-S., Robaszkiewicz, M., Baldi, I., Monnereau, A., Tretarre, B., Colonna, M., Molinié, F., Bara, S., Schvartz, C., Lapôtre-Ledoux, B., Grosclaude, P., Stabenow, R., Luttmann, S., Nennecke, A., Engel, J., SchubertFritschle, G., Heidrich, J., Holleczek, B., Jónasson, J. G., Clough-Gorr, K., Mazzoleni, G., Giacomin, A., Sardo, A. S., Barchielli, A., Serraino, D., Collarile, P., Pannozzo, F., Ricci, P., Autelitano, M., Spagnoli, G., Fusco, M., Usala, M., Vitale, F., Michiara, M., Tumino, R., Mangone, L., Falcini, F., Ferretti, S., Filiberti, R. A., Marani, E., Caiazzo, A. L., Iannelli, A., Sensi, F., Piffer, S., Gentilini, M., Madeddu, A., Colanino, A. Z., Maspero, S., Candela, P., Stracci, F., Tagliabue, G., Rugge, M., Baili, P., Minicozzi, P., Sant, M., Tereanu, C., Francisci, S., Tavilla, A., Pierannunzio, D., Rossi, S., Santaquilani, M., Knijn, A., Pildava, S., Smailyte, G., Calleja, N., Agius, D., Johannesen, T. B., Rachtan, J., Gózdz, S., Blaszczyk, J., Kepska, K., Lacerda, G. F. D., Bento, M. J., Miranda, A., Diba, C. S., Žagar, T., Almar, E., Larrañaga, N., Munain, A. L. D., Torrella-Ramos, A., García, J. M. D., Marcos-Gragera, R., Sanchez, M. J., Navarro, C., Salmeron, D., Moreno-Iribas, C., Galceran, J., Carulla, M., Mousavi, M., Bouchardy, C., Ess, S. M., Bordoni, A., Konzelmann, I., Rashbass, J., Gavin, A., Brewster, D. H., Huws, D. W., Ho, V. K., & Benhamou, E.
- Affiliations
- Fondazione IRCCS Istituto Nazionale dei Tumori (IT)
- Istituto Superiore di Sanità (IT)
- National Cancer Registry (IE)
- Finnish Cancer Registry (FI)
- Netherlands Comprehensive Cancer Organisation (NL)
- Institute of Oncology Ljubljana (SI)
- Queen's University Belfast (GB)
- Policlinico Universitario di Catania (IT)
- Institut Scientifique de Santé Publique (BE)
- Public Health England (GB)
- Instituto de Salud Pública de Navarra (ES)
- Corresponding author
- Gatta, Gemma
- ORCID
- Gatta, Gemma
- Capocaccia, Riccardo
- Botta, Laura
- Mallone, Sandra
- Comber, Harry
- Dimitrova, Nadya
- Leinonen, Maarit K
- Siesling, Sabine
- Visser, Otto
- Anderson, Lesley A
- Stiller, Charles A
- Trama, Annalisa
- Dušek, Ladislav
- Mägi, Margit
- Paapsi, Keiu
- Malila, Nea
- Troussard, Xavier
- Guizard, Anne-Valérie
- Bouvier, Anne-Marie
- Arveux, Patrick
- Maynadié, Marc
- Woronoff, Anne-Sophie
- Robaszkiewicz, Michel
- Baldi, Isabelle
- Monnereau, Alain
- Colonna, Marc
- Molinié, Florence
- Grosclaude, Pascale
- Luttmann, Sabine
- Nennecke, Alice
- Mazzoleni, Guido
- Serraino, Diego
- Vitale, Francesco
- Tumino, Rosario
- Falcini, Fabio
- Ferretti, Stefano
- Filiberti, Rosa Angela
- Piffer, Silvano
- Tagliabue, Giovanna
- Rugge, Massimo
- Baili, Paolo
- Minicozzi, Pamela
- Sant, Milena
- Francisci, Silvia
- Tavilla, Andrea
- Pierannunzio, Daniela
- Rossi, Silvia
- Santaquilani, Mariano
- Knijn, Arnold
- Pildava, Santa
- Calleja, Neville
- Rachtan, Jadwiga
- Miranda, Ana
- Žagar, Tina
- Almar, Enrique
- Larrañaga, Nerea
- García, José María Díaz
- Navarro, Carmen
- Bouchardy, Christine
- Ess, Silvia M.
- Gavin, Anna
- Brewster, David H
- Huws, Dyfed Wyn
- Ho, Vincent KY
- Venue
- The Lancet Oncology
- Publisher
- Elsevier BV
- Published
- 2017-08
- Volume
- 18
- Issue
- 8
- Pages
- 1022-1039
- ISSN
- 1470-2045 (ISSN-L)
- OpenAlex
- W2729284305
- Cited by
- 516
- References
- 22
- Citations by year
- 2026: 60 · 2025: 82 · 2024: 81 · 2023: 71 · 2022: 64 · 2021: 52 · 2020: 47 · 2019: 27 · 2018: 24 · 2017: 6
- FWCI
- 12.46
- Type
- journal article
- Language
- en
- Update notices
- erratum (2017-08-01)
- Open access
- bronze
- doi.org
- Locations
- The Lancet Oncology (publishedVersion)
- PubMed (publishedVersion)
- OAR@UM (University of Malta) (submittedVersion, other-oa)
- HAL (submittedVersion)
- Nova Science Publishers (Nova Science Publishers, Inc.) (submittedVersion)
- Research Portal (Queen's University Belfast) (submittedVersion, other-oa)
- Institutional Research Information System University of Ferrara (University of Ferrara) (submittedVersion, cc-by)
- Padua Research Archive (University of Padova) (submittedVersion)
- Funders
- European Commission through the Consumers, Health, Agriculture and Food Executive Agency (Grant No. 2000111201)
- Topics
- Health Sciences › Medicine › Oncology › Global Cancer Incidence and Screening
- Health Sciences › Medicine › Radiology, Nuclear Medicine and Imaging › Advances in Oncology and Radiotherapy
- Health Sciences › Medicine › Oncology › COVID-19 and healthcare impacts
- Keywords
- rare tumor, cancer incidence, cancer survival, cancer registry, incidence trends, sarcoma, Europe, referral patterns, healthcare resource allocation, cancer care costs
- MeSH terms
- Cancer Care Facilities, Delivery of Health Care, Europe, Female, Hospitalization, Humans, Male, Neoplasms, Registries, Incidence, Survival Rate, Rare Diseases
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
